For example, Song et al indicated radiomics features extracted from pretherapy CT images had a considerable value on prediction of PFS for stage IV EGFR-mutant non-small cell lung cancer (NSCLC) patients who received EGFR-TKI therapy [20]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.